CRH Medical Co. (NYSEAMERICAN:CRHM) was the recipient of a large increase in short interest in the month of November. As of November 30th, there was short interest totalling 1,483,184 shares, an increase of 5.2% from the November 15th total of 1,410,081 shares. Currently, 2.1% of the shares of the company are sold short. Based on an average trading volume of 91,455 shares, the days-to-cover ratio is presently 16.2 days.

Hedge funds and other institutional investors have recently modified their holdings of the business. Vanguard Group Inc. bought a new position in CRH Medical during the 2nd quarter valued at $150,000. Bank of Montreal Can boosted its stake in CRH Medical by 128.4% during the 2nd quarter. Bank of Montreal Can now owns 28,700 shares of the company’s stock valued at $164,000 after purchasing an additional 16,135 shares in the last quarter. Advisor Group Inc. boosted its stake in CRH Medical by 35.0% during the 2nd quarter. Advisor Group Inc. now owns 36,177 shares of the company’s stock valued at $206,000 after purchasing an additional 9,389 shares in the last quarter. PDT Partners LLC boosted its stake in CRH Medical by 176.4% during the 2nd quarter. PDT Partners LLC now owns 50,162 shares of the company’s stock valued at $285,000 after purchasing an additional 32,013 shares in the last quarter. Finally, TD Asset Management Inc. boosted its stake in shares of CRH Medical by 57.7% during the 2nd quarter. TD Asset Management Inc. now owns 67,203 shares of the company’s stock worth $382,000 after acquiring an additional 24,596 shares in the last quarter.

Shares of CRH Medical (CRHM) traded down $0.03 during midday trading on Monday, reaching $2.37. The company’s stock had a trading volume of 216,288 shares, compared to its average volume of 155,649. CRH Medical has a 52-week low of $1.46 and a 52-week high of $9.25.

CRHM has been the subject of a number of research reports. Zacks Investment Research lowered CRH Medical from a “hold” rating to a “sell” rating in a research note on Tuesday, November 14th. Morgan Stanley raised CRH Medical from an “equal weight” rating to an “overweight” rating in a research note on Friday, November 17th. Four research analysts have rated the stock with a hold rating and six have issued a buy rating to the company. The stock has a consensus rating of “Buy” and an average price target of $7.50.

ILLEGAL ACTIVITY NOTICE: “Short Interest in CRH Medical Co. (CRHM) Rises By 5.2%” was originally published by American Banking News and is owned by of American Banking News. If you are reading this story on another publication, it was illegally stolen and republished in violation of US & international trademark and copyright law. The legal version of this story can be read at https://www.americanbankingnews.com/2017/12/11/short-interest-in-crh-medical-co-crhm-rises-by-5-2.html.

CRH Medical Company Profile

CRH Medical Corporation is a Canada-based healthcare products and services company. The Company focused on providing physicians with services and products for the treatment of gastrointestinal diseases. The Company also provides anesthesiology services to gastroenterologists in the United States through its subsidiaries.

Receive News & Ratings for CRH Medical Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CRH Medical Co. and related companies with MarketBeat.com's FREE daily email newsletter.